Natanzon, S.S.; Mansour, M.; Fardman, A.; Chernomordik, F.; Herscovici, R.; Matetzky, S.; Beigel, R.
Intermediate-Risk Pulmonary Embolism: Patients’ Stratification, Prognosis, and Therapeutic Options—Time to Pay Attention to the Middle Child. J. Clin. Med. 2025, 14, 6215.
https://doi.org/10.3390/jcm14176215
AMA Style
Natanzon SS, Mansour M, Fardman A, Chernomordik F, Herscovici R, Matetzky S, Beigel R.
Intermediate-Risk Pulmonary Embolism: Patients’ Stratification, Prognosis, and Therapeutic Options—Time to Pay Attention to the Middle Child. Journal of Clinical Medicine. 2025; 14(17):6215.
https://doi.org/10.3390/jcm14176215
Chicago/Turabian Style
Natanzon, Sharon Shalom, Mahmoud Mansour, Alexander Fardman, Fernando Chernomordik, Romana Herscovici, Shlomi Matetzky, and Roy Beigel.
2025. "Intermediate-Risk Pulmonary Embolism: Patients’ Stratification, Prognosis, and Therapeutic Options—Time to Pay Attention to the Middle Child" Journal of Clinical Medicine 14, no. 17: 6215.
https://doi.org/10.3390/jcm14176215
APA Style
Natanzon, S. S., Mansour, M., Fardman, A., Chernomordik, F., Herscovici, R., Matetzky, S., & Beigel, R.
(2025). Intermediate-Risk Pulmonary Embolism: Patients’ Stratification, Prognosis, and Therapeutic Options—Time to Pay Attention to the Middle Child. Journal of Clinical Medicine, 14(17), 6215.
https://doi.org/10.3390/jcm14176215
